JP Stock MarketDetailed Quotes

MediciNova (4875)

Watchlist
  • 240
  • +12+5.26%
20min DelayMarket Closed Aug 25 15:30 JST
11.81BMarket Cap-6.38P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

MediciNova (4875) Cash Flow

Cumulative·All
YOY yoy
Hide blank lines yoy
Currency: USD
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
2022/Q3
2022/Q2
2022/Q1
2021/Q4
2021/Q3
Operating Cash Flow
+16.75%-1.92M
+8.28%-3.47M
-4.40%-2.02M
+16.18%-1.70M
+17.95%-2.31M
+2.19%-3.78M
-287.07%-1.93M
-48.16%-2.03M
-17.96%-2.81M
-21.74%-3.87M
+87.55%-499.06K
+49.58%-1.37M
+2.97%-2.38M
+14.78%-3.18M
-10.11%-4.01M
+9.80%-2.72M
-317.93%-2.46M
+3.26%-3.73M
-86.70%-3.64M
+22.84%-3.02M
Net cash flow from continuing operations
+16.75%-1.92M
+8.28%-3.47M
-4.40%-2.02M
+16.18%-1.70M
+17.95%-2.31M
+2.19%-3.78M
-287.07%-1.93M
-48.16%-2.03M
-17.96%-2.81M
-21.74%-3.87M
+87.55%-499.06K
+49.58%-1.37M
+2.97%-2.38M
+14.78%-3.18M
-10.11%-4.01M
+9.80%-2.72M
-317.93%-2.46M
+3.26%-3.73M
-86.70%-3.64M
+22.84%-3.02M
Net Income from Continuing Operations
+29.47%-2.31M
+9.70%-2.59M
+0.44%-2.80M
-6.95%-3.05M
-24.85%-3.28M
-3.98%-2.86M
-36.69%-2.81M
-294.43%-2.85M
+8.48%-2.63M
+5.59%-2.75M
+31.40%-2.06M
+80.20%-723.11K
+28.72%-2.87M
+13.85%-2.92M
-44.08%-3.00M
-2.04%-3.65M
+5.96%-4.03M
-1703.21%-3.39M
+30.22%-2.08M
+3.37%-3.58M
Gain/Loss from Continuing Operations
----
----
----
----
----
----
-100.00%1.00
----
----
----
--346.49K
--371.00
--0.00
--102.51K
----
----
----
----
----
----
Depreciation & Depletion & Amortization
-0.87%5.02K
-17.71%4.26K
-12.01%4.56K
+2.37%5.30K
-5.70%5.06K
-3.23%5.18K
-5.74%5.18K
-9.17%5.18K
+7.51%5.37K
+30.33%5.35K
+26.81%5.49K
+27.90%5.70K
+11.30%5.00K
-7.32%4.11K
-32.05%4.33K
-37.79%4.46K
-27.07%4.49K
-31.37%4.43K
+8.86%6.37K
+37.40%7.17K
Stock-Based Compensation
-13.73%176.77K
+42.60%407.76K
-31.60%180.56K
-68.77%157.69K
-1.23%204.90K
+32.73%285.94K
+211.20%263.99K
+130.38%504.86K
-36.31%207.46K
-46.58%215.43K
-284.51%-237.41K
+38.44%219.14K
+18.65%325.71K
+397.53%403.26K
+117.00%128.67K
-72.66%158.30K
-63.69%274.50K
-92.89%81.05K
-290.17%-756.97K
-44.01%578.94K
Other Non-Cash Items
-11.66%41.70K
-10.93%40.55K
-11.49%39.25K
-4.32%41.70K
+30.39%47.21K
-7.83%45.53K
+114.88%44.34K
-8.36%43.58K
-26.30%36.20K
-0.26%49.39K
-236.61%-298.09K
+70.60%47.56K
-12.61%49.12K
+9.61%49.52K
-265.97%-88.56K
-47.15%27.88K
+2.73%56.22K
-19.04%45.18K
-7.11%53.36K
--52.76K
Change in Working Capital
-76.23%170.60K
-6.40%-1.34M
-1.46%561.12K
+328.38%1.14M
+266.21%717.61K
+9.23%-1.26M
-67.34%569.41K
+128.95%266.70K
-496.20%-431.76K
-68.91%-1.38M
+248.71%1.74M
-224.25%-921.22K
-91.20%108.98K
-73.35%-819.31K
-36.51%-1.17M
+1084.29%741.40K
-73.06%1.24M
+90.29%-472.64K
-249.41%-858.87K
+94.61%-75.32K
-Change in Receivables
+282.10%245.10K
---245.10K
----
----
---134.60K
--0.00
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
-Change in Prepaid Assets
-82.60%65.90K
+6.10%-368.10K
-34.34%173.88K
+92.68%369.33K
+195.71%378.79K
+28.95%-392.00K
-15.96%264.82K
+23.33%191.68K
-409.15%-395.75K
-77.46%-551.75K
+57.12%315.11K
+82.07%155.42K
-69.44%128.01K
+43.90%-310.91K
-64.24%200.55K
+220.45%85.36K
+745.07%418.86K
-13.29%-554.17K
+151.42%560.81K
+81.68%-70.87K
-Change in Payables and Accrued Expense
-36.25%336.03K
+9.57%-735.18K
+64.87%582.39K
+41.72%163.33K
+103870.22%527.13K
-4.05%-812.98K
-25.93%353.25K
+500.17%115.25K
-98.33%507.00
-70.14%-781.35K
+135.82%476.91K
-104.09%-28.80K
-96.40%30.37K
-512.43%-459.25K
+1.90%-1.33M
+1404.57%704.14K
+40.07%844.76K
+134.86%111.35K
-431.49%-1.36M
+105.52%46.80K
-Change in Other Current Liabilities
+10.33%-48.16K
+9.66%-46.26K
+10.76%-43.42K
-16.02%-46.67K
-47.09%-53.71K
-0.79%-51.21K
-0.36%-48.65K
+15.91%-40.23K
+26.10%-36.51K
-3.37%-50.81K
-16.01%-48.48K
+0.56%-47.84K
-91.54%-49.41K
-64.80%-49.15K
+33.30%-41.79K
+6.14%-48.11K
+55.81%-25.80K
+49.84%-29.83K
-8.84%-62.66K
---51.25K
-Change In Other Working Capital
---428.28K
--58.12K
---151.74K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net cash flow from investing
--0.00
---10.83K
-100.00%0.00
-1602.07%-2.90K
+100.00%0.00
--0.00
-95.45%1.00
+107.03%193.00
+95.20%-891.00
-100.00%0.00
+100.00%22.00
+99.97%-2.74K
---18.58K
--39.93M
---30.01M
-340267.60%-10.00M
--0.00
--0.00
+100.00%0.00
-146.89%-2.94K
Net Cash Flow from Continuing Investing Activities
--0.00
---10.83K
-100.00%0.00
-1602.07%-2.90K
+100.00%0.00
--0.00
-95.45%1.00
+107.03%193.00
+95.20%-891.00
-100.00%0.00
+100.00%22.00
+99.97%-2.74K
---18.58K
--39.93M
---30.01M
-340267.60%-10.00M
--0.00
--0.00
+100.00%0.00
-146.89%-2.94K
Net PPE Purchase and Sale
--0.00
---10.83K
-100.00%0.00
-1602.07%-2.90K
--0.00
--0.00
-95.45%1.00
+107.03%193.00
----
----
+100.44%22.00
---2.74K
----
----
---5.01K
+100.00%0.00
----
----
+100.00%0.00
-146.89%-2.94K
Net Investment Purchase and Sale
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
+100.00%0.00
+100.00%0.00
--0.00
--39.93M
---30.00M
---10.00M
--0.00
--0.00
--0.00
----
Financing Cash Flow
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
----
----
-89.21%38.70K
-95.13%249.61K
Net Cash Flow from Continuing Financing Activities
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
----
----
-89.21%38.70K
-95.13%249.61K
Net Common Stock Issuance
----
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
----
----
-89.28%38.70K
-95.27%249.61K
Proceeds from Stock Option Exercised
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
-100.00%0.00
Net Other Financing Charges
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
+100.00%0.00
+100.00%0.00
Ending Cash Balance
-25.81%25.42M
-25.27%27.33M
-23.67%30.81M
-22.98%32.56M
-22.73%34.26M
-22.42%36.57M
-20.86%40.36M
-17.91%42.28M
-16.15%44.34M
-14.70%47.14M
+175.59%51.00M
-1.90%51.51M
-18.94%52.88M
-18.37%55.26M
-74.09%18.51M
-30.01%52.51M
-16.14%65.23M
-11.28%67.70M
+18.98%71.43M
+21.67%75.03M
Net Change in Cash
+16.75%-1.92M
+8.00%-3.48M
+8.23%-1.77M
+16.03%-1.71M
+17.97%-2.31M
+2.19%-3.78M
-287.09%-1.93M
-47.85%-2.03M
-17.08%-2.81M
-110.53%-3.87M
+98.53%-499.04K
+89.20%-1.37M
+1.90%-2.40M
+1085.72%36.75M
-844.71%-34.01M
-359.39%-12.72M
-264.20%-2.45M
-122.95%-3.73M
-121.81%-3.60M
-327.31%-2.77M
Beginning Cash Balance
-25.27%27.33M
-23.67%30.81M
-22.98%32.56M
-22.73%34.26M
-22.42%36.57M
-20.86%40.36M
-17.91%42.28M
-16.15%44.34M
-14.70%47.14M
+175.59%51.00M
-1.90%51.51M
-18.94%52.88M
-18.37%55.26M
-74.09%18.51M
-30.01%52.51M
-16.14%65.23M
-11.28%67.70M
+18.98%71.43M
+21.67%75.03M
+28.71%77.79M
Effect of Exchange Rate Changes
+220.87%6.56K
+186.23%3.98K
+53.39%16.64K
+135.79%9.07K
-150.00%-5.42K
-160.63%-4.61K
+222.18%10.85K
-570.83%-25.35K
-41.36%10.85K
+234.58%7.61K
-186.36%-8.88K
+191.95%5.38K
+232.71%18.50K
+131.13%2.27K
+76.19%10.28K
-382.67%-5.85K
-2949.67%-13.94K
-138.23%-7.30K
+503.94%5.84K
-24.99%2.07K
Free Cash Flow
+16.75%-1.92M
+8.00%-3.48M
-4.40%-2.02M
+16.03%-1.71M
+17.97%-2.31M
+2.19%-3.78M
-287.09%-1.93M
-47.85%-2.03M
-17.08%-2.81M
-110.53%-3.87M
+98.53%-499.04K
+89.20%-1.37M
+2.21%-2.40M
+1085.72%36.75M
-834.66%-34.01M
-321.40%-12.72M
-317.93%-2.46M
+3.26%-3.73M
-83.62%-3.64M
+22.78%-3.02M
Deadline
Jun 30, 2026
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Accounting Standard
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
US_GAAP
Audit Opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
2026/Q22026/Q12025/Q42025/Q32025/Q22025/Q12024/Q42024/Q32024/Q22024/Q12023/Q42023/Q32023/Q22023/Q12022/Q42022/Q32022/Q22022/Q12021/Q42021/Q3
Market Insights

- No more -